Stock market today: Dow, S&P 500, Nasdaq futures take a breath after tech selloff

view original post

US stock futures struggled on Wednesday following a rough trading session that saw Wall Street equity markets close deep in the red.

Dow Jones Industrial Average futures (YM=F) hovered just above the flat line, while S&P 500 futures (ES=F) dropped 0.1%. Contracts on the tech-heavy Nasdaq 100 (NQ=F) fell 0.2%, as shares of AI chipmaker AMD (AMD) slid after its earnings beat estimates but nevertheless underwhelmed.

During regular trading on Tuesday, the Nasdaq Composite (^IXIC) led a steep stock slide, falling over 2%. The pullback followed a sharp selloff in tech names, led by Palantir (PLTR), which fell nearly 8% despite topping third-quarter expectations.

The stock’s lofty valuation has some investors questioning whether the AI-fueled rally has left fundamentals behind. Fears of an AI-fueled bubble are beginning to mount, spurred by investor Michael Burry’s puts against both Palantir and Nvidia (NVDA). AMD’s underwhelming earnings reveal could add more fuel to that fire.

In Wednesday’s earnings lineup, McDonald’s (MCD), Qualcomm (QCOM), Robinhood (HOOD), and Toyota (TM) are among the highlights.

On the data front, traders will look to the ADP private payrolls report on Wednesday for clues about the labor market, alongside updates on mortgage applications and ISM services activity. The government shutdown continues to stall economic releases, and on Wednesday will be the longest in history by Wednesday. In the latest development, the Trump administration is warning of “mass chaos” for travellers as officials look at closing airports.

Meanwhile, President Trump’s tariffs face a key test on Wednesday when the Supreme Court hears arguments in a case questioning his legal authority to impose his most sweeping duties. The high court’s decision could have significant reverberations for the global economy.

LIVE 3 updates

  • Novo Nordisk lowers full-year profit guidance

    Novo Nordisk (NVO, NOVO-B.CO) cut its forecasts for full-year profit and sales on Wednesday, as its new CEO drives a push to regain ground lost amid fierce competition in the weight-loss drug market.

    US-listed shares in the Ozempic and Wegovy maker rose almost 3% in premarket as investors digested the Danish drugmaker’s quarterly earnings release.

    Reuters reported:

    Read more here.

  • Asian markets fall in response to tech sell-off

    Asian markets fell in tandem with US gauges as the global market followed a tech sell-off trend. Investor appetite for sky-high AI spend appears to have hit a ceiling as fears of over-inflated AI valuations spread.

    South Korea’s Kospi (^KS11) fell over 6% before pulling back to a 3% drop.

    Japan’s benchmark, the Nikkei 225 (^N225) levelled off at losses of 2.8%

    Hong Kong’s Hang Seng index (^HSI) slipped 0.5%.

    The fall came following a day of heavy losses for major American gauges as AI tech darlings like Palantir fell despite solid earnings reports.

  • Gold falters around the $4000 mark

    Gold (GC=F) continues to struggle around the $4,000 mark following a record-setting run, as a strong dollar, combined with the Fed’s rate cuts, has dampened haven demand.

    Bloomberg reports:

    Read more here.